Activation-induced and damage-induced cell death in aging human T cells

Mechanisms of Ageing and Development

Volumn 151, Issue , 2015, Pages 85-92

  Sikora, Ewa ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Apoptosis; Autophagy; DNA damage; Immunosenescence; Inflammaging; Lymphocytes; Necroptosis

Indexed keywords

CASPASE 8; CD28 ANTIGEN; CD8 ANTIGEN; ENDONUCLEASE G; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

ACTIVATION INDUCED CELL DEATH; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CELL DEATH; CONTROLLED STUDY; DAMAGE INDUCED CELL DEATH; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSENESCENCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; NECROPTOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SENESCENCE; T LYMPHOCYTE; AGING; IMMUNOLOGY;

AGING; APOPTOSIS; CELL AGING; HUMANS; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; RECEPTORS, ANTIGEN, T-CELL;

EID: 84947021431     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2015.03.011     Document Type: Article

References (93)

1. Aggarwal S., Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J. Immunol. 1998, 160:1627-1637.
2. Aggarwal S., Gollapudi S., Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol. 1999, 162:2154-2161.
3. Arnold R., Brenner D., Becker M., Frey C.R., Krammer P.H. How T lymphocytes switch between life and death. Eur. J. Immunol. 2006, 36:1654-1658.
4. Arnold C.R., Pritz T., Brunner S., Knabb C., Salvenmoser W., Holzwarth B., Thedieck K., Grubeck-Loebenstein B. T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells. Exp. Gerontol. 2014, 54:75-83.
5. Behrens M.I., Silva M., Schmied A., Salech F., Manzur H., Rebolledo R., Bull R., Torres V., Henriquez M., Quest A.F. Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:732-740.
6. Behrens M.I., Silva M., Salech F., Ponce D.P., Merino D., Sinning M., Xiong C., Roe C.M., Quest A.F. Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:1036-1040.
7. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A., Morrissette N.S., Walsh C.M. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16677-16682.
8. Brenner D., Golks A., Kiefer F., Krammer P.H., Arnold R. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. EMBO J. 2005, 24:4279-4290.
9. Brunner S., Herndler-Brandstetter D., Arnold C.R., Wiegers G.J., Villunger A., Hackl M., Grillari J., Moreno-Villanueva M., Burkle A., Grubeck-Loebenstein B. Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell 2012.
10. Brzezinska A., Magalska A., Sikora E. Proliferation of CD8+ in culture of human T cells derived from peripheral blood of adult donors and cord blood of newborns. Mech. Ageing Dev. 2003, 124:379-387.
11. Brzezinska A., Magalska A., Szybinska A., Sikora E. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging. Exp. Gerontol. 2004, 39:539-544.
12. Brzezinska A. Does in vitro replicative senescence of human CD8+ cells reflect the phenotypic changes observed during in vivo ageing?. Acta Biochim. Pol. 2005, 52:931-935.
13. Campisi J. Cancer and ageing: rival demons?. Nat. Rev. Cancer 2003, 3:339-349.
14. Capri M., Monti D., Salvioli S., Lescai F., Pierini M., Altilia S., Sevini F., Valensin S., Ostan R., Bucci L., Franceschi C. Complexity of anti-immunosenescence strategies in humans. Artif. Organs 2006, 30:730-742.
15. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., Hoffmann A., Hedrick S.M. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17463-17468.
16. Chen W.H., Kozlovsky B.F., Effros R.B., Grubeck-Loebenstein B., Edelman R., Sztein M.B. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009, 30:351-359.
17. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13:994-1002.
18. Christofferson D.E., Yuan J. Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol. 2010, 22:263-268.
19. De Martinis, Franceschi C., Monti D., Ginaldi L. Apoptosis remodeling in immunosenescence: implications for strategies to delay ageing. Curr. Med. Chem. 2007, 14:1389-1397.
20. Dejaco C., Duftner C., Klauser A., Schirmer M. Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. Rheumatol. Int. 2010, 30:297-303.
21. Dennett N.S., Barcia R.N., McLeod J.D. Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Exp. Gerontol. 2002, 37:271-283.
22. Donnini A., Re F., Bollettini M., Moresi R., Tesei S., Bernardini G., Provinciali M. Age-related susceptibility of naive and memory CD4T cells to apoptosis induced by IL-2 deprivation or PHA addition. Biogerontology 2005, 6:193-204.
23. Dumitriu I.E., Araguas E.T., Baboonian C., Kaski J.C. CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc. Res. 2009, 81:11-19.
24. Effros R.B., Dagarag M., Spaulding C., Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 2005, 205:147-157.
25. Fagnoni F.F., Vescovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., Casti A., Franceschi C., Passeri M., Sansoni P. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000, 95:2860-2868.
26. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging: An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
27. Freund A., Orjalo A.V., Desprez P.Y., Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010, 16:238-246.
28. Ginaldi L., De Martinis M., Monti D., Franceschi C. The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol. Res. 2004, 30:81-94.
29. Ginaldi L., De Martinis M., Monti D., Franceschi C. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol. 2005, 26:79-84.
30. Giovannetti A., Pierdominici M., Di Iorio A., Cianci R., Murdaca G., Puppo F., Pandolfi F., Paganelli R. Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr. Pharm. Des. 2008, 14:253-268.
31. Green D.R., Droin N., Pinkoski M. Activation-induced cell death in T cells. Immunol. Rev. 2003, 193:70-81.
32. Hayflick L. The illusion of cell immortality. Br. J. Cancer 2000, 83:841-846.
33. Herndon F.J., Hsu H.C., Mountz J.D. Increased apoptosis of CD45RO- T cells with aging. Mech. Ageing Dev. 1997, 94:123-134.
34. Hoare M., Narita M. Transmitting senescence to the cell neighbourhood. Nat. Cell Biol. 2013, 15:887-889.
35. Hsu H.C., Scott D.K., Mountz J.D. Impaired apoptosis and immune senescence - cause or effect?. Immunol. Rev. 2005, 205:130-146.
36. Jeyapalan J.C., Sedivy J.M. Cellular senescence and organismal aging. Mech. Ageing Dev. 2008, 129:467-474.
37. Joaquin A.M., Gollapudi S. Functional decline in aging and disease: a role for apoptosis. J. Am. Geriatrics Soc. 2001, 49:1234-1240.
38. Kirchhoff S., Muller W.W., Li-Weber M., Krammer P.H. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 2000, 30:2765-2774.
39. Kirkwood T.B. A systematic look at an old problem. Nature 2008, 451:644-647.
40. Krammer P.H., Arnold R., Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7:532-542.
41. Krueger A., Fas S.C., Baumann S., Krammer P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003, 193:58-69.
42. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev. 2010, 24:2463-2479.
43. Lechner H., Amort M., Steger M.M., Maczek C., Grubeck-Loebenstein B. Regulation of CD95 (APO-1) expression and the induction of apoptosis in human T cells: changes in old age. Int. Arch. Allergy Immunol. 1996, 110:238-243.
44. Li H., Manwani B., Leng S.X. Frailty, inflammation, and immunity. Aging Dis. 2011, 2:466-473.
45. Lockshin R.A., Zakeri Z. Programmed cell death and apoptosis: origins of the theory. Nat. Rev. Mol. Cell Biol. 2001, 2:545-550.
46. Lu B., Finn O.J. T-cell death and cancer immune tolerance. Cell Death Differ. 2008, 15:70-79.
47. Lu J.V., Walsh C.M. Programmed necrosis and autophagy in immune function. Immunol. Rev. 2012, 249:205-217.
48. Lurain N.S., Hanson B.A., Martinson J., Leurgans S.E., Landay A.L., Bennett D.A., Schneider J.A. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J. Infect. Dis. 2013, 208:564-572.
49. McLeod J.D., Walker L.S., Patel Y.I., Boulougouris G., Sansom D.M. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J. Immunol. 1998, 160:2072-2079.
50. Monti D., Salvioli S., Capri M., Malorni W., Straface E., Cossarizza A., Botti B., Piacentini M., Baggio G., Barbi C., Valensin S., Bonafe M., Franceschi C. Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians. Mech. Ageing Dev. 2000, 121:239-250.
51. Munoz-Espin D., Canamero M., Maraver A., Gomez-Lopez G., Contreras J., Murillo-Cuesta S., Rodriguez-Baeza A., Varela-Nieto I., Ruberte J., Collado M., Serrano M. Programmed cell senescence during mammalian embryonic development. Cell 2013, 155:1104-1118.
52. Osborne B.A. Apoptosis and the maintenance of homoeostasis in the immune system. Curr. Opin. Immunol. 1996, 8:245-254.
53. Pallis A.G., Hatse S., Brouwers B., Pawelec G., Falandry C., Wedding U., Lago L.D., Repetto L., Ring A., Wildiers H. Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?. J. Geriatric Oncol. 2014, 5:204-218.
54. Palmer E. Negative selection - clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 2003, 3:383-391.
55. Pasparakis M., Vandenabeele P. Necroptosis and its role in inflammation. Nature 2015, 517:311-320.
56. Pawelec G., Sansom D., Rehbein A., Adibzadeh M., Beckman I. Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp. Gerontol. 1996, 31:655-668.
57. Pawelec G., Goldeck D., Derhovanessian E. Inflammation, ageing and chronic disease. Curr. Opin. Immunol. 2014, 29:23-28.
58. Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp. Gerontol. 2014, 54:1-5.
59. Phelouzat M.A., Laforge T., Arbogast A., Quadri R.A., Boutet S., Proust J.J. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech. Ageing Dev. 1997, 96:35-46.
60. Pinti M., Troiano L., Nasi M., Bellodi C., Ferraresi R., Mussi C., Salvioli G., Cossarizza A. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century. Circulation 2004, 110:3108-3114.
61. Ponce D.P., Salech F., SanMartin C.D., Silva M., Xiong C., Roe C.M., Henriquez M., Quest A.F., Behrens M.I. Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity. Curr. Alzheimer Res. 2014, 11:892-898.
62. Posnett D.N., Edinger J.W., Manavalan J.S., Irwin C., Marodon G. Differentiation of human CD8T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones. Int. Immunol. 1999, 11:229-241.
63. Potestio M., Caruso C., Gervasi F., Scialabba G., D'Anna C., Di Lorenzo G., Balistreri C.R., Candore G., Romano G.C. Apoptosis and ageing. Mech. Ageing Dev. 1998, 102:221-237.
64. Potestio M., Pawelec G., Di Lorenzo G., Candore G., D'Anna C., Gervasi F., Lio D., Tranchida G., Caruso C., Romano G.C. Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp. Gerontol. 1999, 34:659-673.
65. Prado-Garcia H., Romero-Garcia S., Aguilar-Cazares D., Meneses-Flores M., Lopez-Gonzalez J.S. Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Clin. Dev. Immunol. 2012, 2012:741741.
66. Radziszewska E., Piwocka K., Skierski J., Sikora E. UVC-induced cell death of IL-2-dependent human lymphocytes. Cell Biol. Int. 1999, 23:97-103.
67. Radziszewska E., Piwocka K., Bielak-Zmijewska A., Skierski J., Sikora E. Effect of aging on UVC-induced apoptosis of rat splenocytes. Acta Biochim. Pol. 2000, 47:339-347.
68. Rodier F., Campisi J. Four faces of cellular senescence. J. Cell Biol. 2011, 192:547-556.
69. Salminen A., Ojala J., Kaarniranta K. Apoptosis and aging: increased resistance to apoptosis enhances the aging process. Cell Mol. Life Sci. 2011, 68:1021-1031.
70. Schindowski K., Leutner S., Muller W.E., Eckert A. Age-related changes of apoptotic cell death in human lymphocytes. Neurobiol. Aging 2000, 21:661-670.
71. Schirmer M., Goldberger C., Wurzner R., Duftner C., Pfeiffer K.P., Clausen J., Neumayr G., Falkenbach A. Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res. 2002, 4:71-76.
72. Semba R.D., Margolick J.B., Leng S., Walston J., Ricks M.O., Fried L.P. T cell subsets and mortality in older community-dwelling women. Exp. Gerontol. 2005, 40:81-87.
73. Sikora E., Arendt T., Bennett M., Narita M. Impact of cellular senescence signature on ageing research. Ageing Res. Rev. 2011, 10:146-152.
74. Sikora E. Rejuvenation of senescent cells-the road to postponing human aging and age-related disease?. Exp. Gerontol. 2013, 48:661-666.
75. Spaulding C., Guo W., Effros R.B. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp. Gerontol. 1999, 34:633-644.
76. Sprent J., Tough D.F. T cell death and memory. Science 2001, 293:245-248.
77. Storer M., Mas A., Robert-Moreno A., Pecoraro M., Ortells M.C., Di Giacomo V., Yosef R., Pilpel N., Krizhanovsky V., Sharpe J., Keyes W.M. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013, 155:1119-1130.
78. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994, 76:969-976.
79. Valdor R., Macian F. Autophagy and the regulation of the immune response. Pharmacol. Res. J. Ital. Pharmacol. Soc. 2012, 66:475-483.
80. Vallejo A.N., Schirmer M., Weyand C.M., Goronzy J.J. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J. Immunol. 2000, 165:6301-6307.
81. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 2005, 205:158-169.
82. Vasto S., Colonna-Romano G., Larbi A., Wikby A., Caruso C., Pawelec G. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun. Ageing 2007, 4:2.
83. Walker L.S., McLeod J.D., Boulougouris G., Patel Y.I., Hall N.D., Sansom D.M. Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunology 1998, 94:41-47.
84. Walsh C.M., Edinger A.L. The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis. Immunol. Rev. 2010, 236:95-109.
85. Wang C., Jurk D., Maddick M., Nelson G., Martin-Ruiz C., von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 2009, 8:311-323.
86. Warner H.R. Apoptosis: a two-edged sword in aging. Ann. N. Y. Acad Sci. 1999, 887:1-11.
87. Warner H.R. Is cell death and replacement a factor in aging?. Mech. Ageing Dev. 2007, 128:13-16.
88. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317.
89. Widlak P., Garrard W.T. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J. Cell Biochem. 2005, 94:1078-1087.
90. Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Lofgren S., Nilsson B.O., Ernerudh J., Pawelec G., Johansson B. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:556-565.
91. Zanni F., Vescovini R., Biasini C., Fagnoni F., Zanlari L., Telera A., Di Pede P., Passeri G., Pedrazzoni M., Passeri M., Franceschi C., Sansoni P. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp. Gerontol. 2003, 38:981-987.
92. Zimniak P. What is the proximal cause of aging?. Front. Gen. 2012, 3:189.
93. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 2008, 8:512-522.